The USFDA had issued an Emergency Use Authorization (EUA) to Gilead Sciences Inc for emergency use of remdesivir for the treatment of COVID-19 patients.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3eqSNEc
via IFTTT
Cipla launches generic remdesivir for COVID-19 patients
The USFDA had issued an Emergency Use Authorization (EUA) to Gilead Sciences Inc for emergency use of remdesivir for the treatment of COVID-19 patients.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3eqSNEc
via IFTTT
0 comments:
Post a Comment